Skip to main content
. 2020 Sep 4;18:341. doi: 10.1186/s12967-020-02487-6

Fig. 3.

Fig. 3

TMA after application of MCT4 antibody. A representative view (magnification X50) of an individual mesothelioma case positive for MCT4, on the left, and a non-malignant pleura tissue negative for MCT4 protein, on the right